|
Cerebrospinal Fluid
Citations 31-35 of 35 total displayed.
|
Past content
(since Feb 2006):
|
- BRIEF COMMUNICATIONS
CSF neurofilament levels: A potential prognostic marker in Guillain–Barré syndrome
- A. Petzold, N. Hinds, NM F. Murray, N. P. Hirsch, D. Grant, G. Keir, E. J. Thompson, and M. M. Reilly
Neurology 2006; 67: 1071-1073.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Recurrent ibuprofen-induced aseptic meningitis: Evidence against an antigen-specific immune response
- D. Periard, C. Mayor, V. Aubert, and F. Spertini
Neurology 2006; 67: 539-540.
[Full text]
[PDF]
- ARTICLES
Identification of potential CSF biomarkers in ALS
- G. M. Pasinetti, L. H. Ungar, D. J. Lange, S. Yemul, H. Deng, X. Yuan, R. H. Brown, M. E. Cudkowicz, K. Newhall, E. Peskind, S. Marcus, and L. Ho
Neurology 2006; 66: 1218-1222.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Axonal damage markers in cerebrospinal fluid are increased in ALS
- J. Brettschneider, A. Petzold, S. D. Süßmuth, A. C. Ludolph, and H. Tumani
Neurology 2006; 66: 852-856.
[Abstract]
[Full text]
[PDF]
- ARTICLES
CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis
- K. L. Tyler, J. Pape, R. J. Goody, M. Corkill, and B. K. Kleinschmidt-DeMasters
Neurology 2006; 66: 361-365.
[Abstract]
[Full text]
[PDF]
|
|
